A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

Clinical trial NCT01937832 · UNKNOWN

Trial details

NCT number: NCT01937832
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Community Acquired Pneumonia

Start date: 2013-10-01
Primary completion: 2015-10-01
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.